FindTrial
Sign In

Clinical study of safflower yellow on the treatment in severe sepsis and septic shock

Clinical study of safflower yellow on the treatment in severe sepsis and septic shock

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-14005196
Enrollment
Unknown
Registered
2014-06-21
Start date
2012-03-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

severe sepsis and septic shock

Interventions

Study Group:safflower yellow
Control Group:conventional therapy

Sponsors

The people's Hospital of Pujiang County, Sichuan Province, China
Lead Sponsor

Eligibility

Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Signed informed consent; 2. According to the diagnostic standard 2012 severe sepsis and septic shock treatment international guidelines defined; 3. aged 18 to 85 years.

Exclusion criteria

Exclusion criteria: 1. Hypovolemic shock, cardiogenic shock, distributive shock and obstructive shock; 2. pregnant or lactating women; 3. Patient is allergic to safflower yellow; 4. Patient is currently in other medical research; 5. The patients with serious diseases of liver and kidney, hematopoietic system endocrine system; 6. Coagulation disorders, bleeding tendency.

Design outcomes

Primary

MeasureTime frame
The 28 day mortality;ICU hospitalization;Days of Mechanical ventilation;The curve of 28 day survival rate;—

Countries

China

Contacts

Public ContactXiaojin Li
939590330@qq.com+86 18980808557

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 2, 2026